🇪🇸 Spain Country × Condition
pancreatic adenocarcinoma metastatic Clinical Trials in Spain
Active clinical trials for pancreatic adenocarcinoma metastatic with research sites in Spain. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 1, Phase 2, Phase 1 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇪🇸 Spain
Active Trials in Spain (2)
NCT07284277 Phase 1, Phase 2
Recruiting
TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC)
Enrollment
30 pts
Country
🇪🇸 Spain
Clinica Universidad de Navarra, Uni...
View Trial → NCT07377045 Phase 1
Recruiting
Clinical Trial of OMTX705 in Combination With Gemcitabine/Nab-Paclitaxel and Tislelizumab in Patients With Advanced/Metastatic Pancreatic Adenocarcinoma
Enrollment
69 pts
Country
🇪🇸 Spain
Oncomatryx Biopharma S.L.
View Trial → Frequently Asked Questions
How many pancreatic adenocarcinoma metastatic clinical trials are active in Spain?
There are currently 2 active clinical trials for pancreatic adenocarcinoma metastatic with sites in Spain, of which 2 are actively recruiting patients.
How can I join a pancreatic adenocarcinoma metastatic clinical trial in Spain?
To join a pancreatic adenocarcinoma metastatic clinical trial in Spain, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Spain directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are pancreatic adenocarcinoma metastatic trials in Spain?
Active pancreatic adenocarcinoma metastatic trials in Spain span Phase 1, Phase 2, Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology